(Q51709677)

10 April 2018

title

Introduction: oxidation and inflammation, a molecular link between non-communicable diseases. (English)

1 reference

10 April 2018

author

Anabel García-Heredia

series ordinal

2

1 reference

10 April 2018

author name string

Jordi Camps

series ordinal

1

1 reference

10 April 2018

language of work or name

English

0 references

publication date

1 January 2014

1 reference

10 April 2018

Advances in Experimental Medicine and Biology

published in

1 reference

10 April 2018

volume

824

1 reference

10 April 2018

page(s)

1-4

1 reference

10 April 2018

Tackling non-communicable diseases in low- and middle-income countries: is the evidence from high-income countries all we need?

cites work

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-07320-0_1

The 2011 United Nations high-level meeting on non-communicable diseases: the Africa agenda calls for a 5-by-5 approach

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-07320-0_1

Phylogenetic perspectives in innate immunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-07320-0_1

The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-07320-0_1

Insulin resistance, inflammation, and obesity: role of monocyte chemoattractant protein-1 (or CCL2) in the regulation of metabolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-07320-0_1

Hepatic steatosis, low-grade chronic inflammation and hormone/growth factor/adipokine imbalance

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-07320-0_1

Metabolomic assessment of the effect of dietary cholesterol in the progressive development of fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-07320-0_1

Paraoxonases and chemokine (C-C motif) ligand-2 in noncommunicable diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-07320-0_1

Scaling up interventions for chronic disease prevention: the evidence

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-07320-0_1

Impaired paraoxonase-1 status in obese children. Relationships with insulin resistance and metabolic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-07320-0_1

The role of free radicals in the aging brain and Parkinson's Disease: convergence and parallelism

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-07320-0_1

Cellular and molecular mechanisms of mitochondrial function

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-07320-0_1

Mitochondria drive autophagy pathology via microtubule disassembly: a new hypothesis for Parkinson disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-07320-0_1

Skeletal muscle mitochondrial dysfunction precedes right ventricular impairment in experimental pulmonary hypertension.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-07320-0_1

Mitochondria and endocrine function of adipose tissue

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-07320-0_1

Overexpression of oxidored-nitro domain containing protein 1 inhibits human nasopharyngeal carcinoma and cervical cancer cell proliferation and induces apoptosis: Involvement of mitochondrial apoptotic pathways.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-07320-0_1

Sjøgren's syndrome-associated oxidative stress and mitochondrial dysfunction: prospects for chemoprevention trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-07320-0_1

The Mediterranean-type diet: is there a need for further modification?

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-07320-0_1

The continuous administration of aspirin attenuates atherosclerosis in apolipoprotein E-deficient mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-07320-0_1

Resolution of inflammation in obesity-induced liver disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-07320-0_1

The role of impaired mitochondrial lipid oxidation in obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-07320-0_1

Obesity, Visceral Fat, and NAFLD: Querying the Role of Adipokines in the Progression of Nonalcoholic Fatty Liver Disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-07320-0_1

Dietary cholesterol and differential monocyte chemoattractant protein-1 gene expression in aorta and liver of apo E-deficient mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-07320-0_1

The paraoxonases: role in human diseases and methodological difficulties in measurement.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-07320-0_1

Nutrigenomics and nutrigenetics of ω3 polyunsaturated fatty acids

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-07320-0_1

Ubiquitous transgenic overexpression of C-C chemokine ligand 2: a model to assess the combined effect of high energy intake and continuous low-grade inflammation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-07320-0_1

Role of advanced glycation end products in cellular signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-07320-0_1

Lung cancer biomarkers for the assessment of modified risk tobacco products: an oxidative stress perspective

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-07320-0_1

10.1007/978-3-319-07320-0_1

31 March 2020

Identifiers

DOI

1 reference

10 April 2018

1 reference

10 April 2018